Lataa...
Effects of the novel glycopeptide opioid agonist MMP-2200 in preclinical models of Parkinson's disease
In Parkinson's disease (PD), the consequence of dopaminergic denervation is an imbalance in the activity of the direct and indirect striatofugal pathways, which include potentially important changes in opioid peptide expression and/or activity. The systemic administration of a novel glycosylate...
Tallennettuna:
| Päätekijät: | , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2011
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3167001/ https://ncbi.nlm.nih.gov/pubmed/21840512 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.brainres.2011.07.038 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|